STAT+: Pharmalittle: We’re watching a ban compounded versions of GLP-1s, a Biogen acquisition, and more
STAT
MAY 22, 2024
A drug often used off-label to treat alcohol use disorder might provide better benefits than therapies approved for this indication, STAT tells us. Data presented this week at the Digestive Disease Week meeting in D.C. Data presented this week at the Digestive Disease Week meeting in D.C.
Let's personalize your content